Sharda Cropchem Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Sharda Cropchem wird ein jährliches Gewinn- und Umsatzwachstum von 29.9% bzw. 14.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 29.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.5% betragen.

Wichtige Informationen

29.9%

Wachstumsrate der Gewinne

29.9%

EPS-Wachstumsrate

Chemicals Gewinnwachstum22.9%
Wachstumsrate der Einnahmen14.8%
Zukünftige Eigenkapitalrendite14.5%
Analystenabdeckung

Low

Zuletzt aktualisiert29 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates

Oct 30
Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates

Sharda Cropchem Limited Just Beat Revenue Estimates By 10%

Jul 27
Sharda Cropchem Limited Just Beat Revenue Estimates By 10%

Recent updates

Sharda Cropchem Limited (NSE:SHARDACROP) Soars 43% But It's A Story Of Risk Vs Reward

Nov 06
Sharda Cropchem Limited (NSE:SHARDACROP) Soars 43% But It's A Story Of Risk Vs Reward

Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates

Oct 30
Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sharda Cropchem Limited's (NSE:SHARDACROP) CEO For Now

Aug 03
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sharda Cropchem Limited's (NSE:SHARDACROP) CEO For Now

Sharda Cropchem Limited Just Beat Revenue Estimates By 10%

Jul 27
Sharda Cropchem Limited Just Beat Revenue Estimates By 10%

Sharda Cropchem (NSE:SHARDACROP) Has Affirmed Its Dividend Of ₹3.00

Jul 18
Sharda Cropchem (NSE:SHARDACROP) Has Affirmed Its Dividend Of ₹3.00

Sharda Cropchem's (NSE:SHARDACROP) Soft Earnings Are Actually Better Than They Appear

Jul 17
Sharda Cropchem's (NSE:SHARDACROP) Soft Earnings Are Actually Better Than They Appear

Why Investors Shouldn't Be Surprised By Sharda Cropchem Limited's (NSE:SHARDACROP) 29% Share Price Surge

Jul 02
Why Investors Shouldn't Be Surprised By Sharda Cropchem Limited's (NSE:SHARDACROP) 29% Share Price Surge

Does This Valuation Of Sharda Cropchem Limited (NSE:SHARDACROP) Imply Investors Are Overpaying?

Jun 05
Does This Valuation Of Sharda Cropchem Limited (NSE:SHARDACROP) Imply Investors Are Overpaying?

What Does Sharda Cropchem Limited's (NSE:SHARDACROP) Share Price Indicate?

Apr 04
What Does Sharda Cropchem Limited's (NSE:SHARDACROP) Share Price Indicate?

Need To Know: Analysts Just Made A Substantial Cut To Their Sharda Cropchem Limited (NSE:SHARDACROP) Estimates

Oct 27
Need To Know: Analysts Just Made A Substantial Cut To Their Sharda Cropchem Limited (NSE:SHARDACROP) Estimates

Analysts Just Made A Major Revision To Their Sharda Cropchem Limited (NSE:SHARDACROP) Revenue Forecasts

Jul 26
Analysts Just Made A Major Revision To Their Sharda Cropchem Limited (NSE:SHARDACROP) Revenue Forecasts

Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00

Jul 09
Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00

Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?

Jun 07
Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?

Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00

Jan 27
Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00

At ₹498, Is Sharda Cropchem Limited (NSE:SHARDACROP) Worth Looking At Closely?

Dec 06
At ₹498, Is Sharda Cropchem Limited (NSE:SHARDACROP) Worth Looking At Closely?

Do Sharda Cropchem's (NSE:SHARDACROP) Earnings Warrant Your Attention?

Sep 22
Do Sharda Cropchem's (NSE:SHARDACROP) Earnings Warrant Your Attention?

Sharda Cropchem's (NSE:SHARDACROP) Dividend Will Be ₹3.00

Jul 20
Sharda Cropchem's (NSE:SHARDACROP) Dividend Will Be ₹3.00

Sharda Cropchem (NSE:SHARDACROP) Will Pay A Dividend Of ₹3.00

Jul 06
Sharda Cropchem (NSE:SHARDACROP) Will Pay A Dividend Of ₹3.00

When Should You Buy Sharda Cropchem Limited (NSE:SHARDACROP)?

Jun 15
When Should You Buy Sharda Cropchem Limited (NSE:SHARDACROP)?

Is There An Opportunity With Sharda Cropchem Limited's (NSE:SHARDACROP) 41% Undervaluation?

May 31
Is There An Opportunity With Sharda Cropchem Limited's (NSE:SHARDACROP) 41% Undervaluation?

I Ran A Stock Scan For Earnings Growth And Sharda Cropchem (NSE:SHARDACROP) Passed With Ease

May 17
I Ran A Stock Scan For Earnings Growth And Sharda Cropchem (NSE:SHARDACROP) Passed With Ease

Sharda Cropchem (NSE:SHARDACROP) Looks To Prolong Its Impressive Returns

Apr 01
Sharda Cropchem (NSE:SHARDACROP) Looks To Prolong Its Impressive Returns

We Think Sharda Cropchem (NSE:SHARDACROP) Can Stay On Top Of Its Debt

Mar 03
We Think Sharda Cropchem (NSE:SHARDACROP) Can Stay On Top Of Its Debt

Calculating The Intrinsic Value Of Sharda Cropchem Limited (NSE:SHARDACROP)

Feb 12
Calculating The Intrinsic Value Of Sharda Cropchem Limited (NSE:SHARDACROP)

New Forecasts: Here's What Analysts Think The Future Holds For Sharda Cropchem Limited (NSE:SHARDACROP)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Sharda Cropchem Limited (NSE:SHARDACROP)

Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?

Jan 26
Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?

Sharda Cropchem (NSE:SHARDACROP) Will Be Hoping To Turn Its Returns On Capital Around

Dec 27
Sharda Cropchem (NSE:SHARDACROP) Will Be Hoping To Turn Its Returns On Capital Around

Increases to CEO Compensation Might Be Put On Hold For Now at Sharda Cropchem Limited (NSE:SHARDACROP)

Jul 22
Increases to CEO Compensation Might Be Put On Hold For Now at Sharda Cropchem Limited (NSE:SHARDACROP)

Gewinn- und Umsatzwachstumsprognosen

NSEI:SHARDACROP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/202750,4524,5991,7845,7695
3/31/202643,3223,6591,9065,0695
3/31/202537,5292,6382,0234,1185
9/30/202435,0652,1783,4596,293N/A
6/30/202433,1041,478N/AN/AN/A
3/31/202431,6303196923,413N/A
12/31/202332,996873N/AN/AN/A
9/30/202337,1761,9107853,267N/A
6/30/202338,5842,307N/AN/AN/A
3/31/202340,4523,4208423,283N/A
12/31/202239,9783,201N/AN/AN/A
9/30/202238,6033,139-5652,064N/A
6/30/202238,0193,338N/AN/AN/A
3/31/202235,7983,4933332,671N/A
12/31/202132,3343,062N/AN/AN/A
9/30/202128,4742,5231,0843,349N/A
6/30/202126,2942,394N/AN/AN/A
3/31/202123,9562,2921522,464N/A
12/31/202021,8352,369N/AN/AN/A
9/30/202020,7221,9451,1442,972N/A
6/30/202019,7141,698N/AN/AN/A
3/31/202020,0301,647-2971,463N/A
12/31/201918,9431,286N/AN/AN/A
9/30/201919,8241,4311,9253,855N/A
6/30/201919,6801,649N/AN/AN/A
3/31/201919,9761,7634,1315,561N/A
12/31/201820,0721,840N/AN/AN/A
9/30/201818,6121,736N/AN/AN/A
6/30/201818,2941,818N/AN/AN/A
3/31/201817,0661,908N/A170N/A
12/31/201715,3961,763N/AN/AN/A
9/30/201714,5711,840N/AN/AN/A
6/30/201714,2571,927N/AN/AN/A
3/31/201713,9921,904N/A1,815N/A
12/31/201613,2291,918N/AN/AN/A
9/30/201612,6631,861N/AN/AN/A
6/30/201612,5631,795N/AN/AN/A
3/31/201612,2211,751N/A1,966N/A
12/31/201510,3561,167N/AN/AN/A
9/30/201510,4021,136N/AN/AN/A
6/30/201510,6971,159N/AN/AN/A
3/31/201510,6161,230N/A461N/A
12/31/201410,0151,242N/AN/AN/A
9/30/20149,6051,207N/AN/AN/A
6/30/20148,7641,237N/AN/AN/A
3/31/20147,9041,111N/A1,563N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SHARDACROPDas prognostizierte Gewinnwachstum (29.9% pro Jahr) liegt über der Sparquote (6.7%).

Ertrag vs. Markt: SHARDACROPDie Erträge des Unternehmens (29.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (18% pro Jahr).

Hohe Wachstumserträge: SHARDACROPEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: SHARDACROPDie Einnahmen des Unternehmens (14.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.5% pro Jahr).

Hohe Wachstumseinnahmen: SHARDACROPDie Einnahmen des Unternehmens (14.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SHARDACROPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.5%).


Wachstumsunternehmen entdecken